Bamlanivimab

Rarity: Common

The most frequent rarity: most Wikipedia articles become Commons.

Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.

At a glance

Class

Invention

Domain

Science and technology

Knowledge cost

4

In collections

Nobody has pulled it yet.

What Wikipedia says

Bamlanivimab is a monoclonal antibody developed by AbCellera Biologics and Eli Lilly as a treatment for COVID-19. The medication was granted an emergency use authorization (EUA) by the US Food and Drug Administration (FDA) in November 2020, and the EUA was revoked in April 2021.

Excerpt from the Wikipedia article “Bamlanivimab”, under the CC BY-SA 4.0 license. Read the article on Wikipedia